Breastcancer.org, Ardmore, Pennsylvania.
Socanna, Narberth, Pennsylvania.
Cancer. 2022 Jan 1;128(1):160-168. doi: 10.1002/cncr.33906. Epub 2021 Oct 12.
The goal of this study was to characterize cannabis use among patients with breast cancer, including their reasons for and timing of use, their sources of cannabis information and products, their satisfaction with the information found, their perceptions of its safety, and their dialogue about cannabis with their physicians.
United States-based members of the Breastcancer.org and Healthline.com communities with a self-reported diagnosis of breast cancer within 5 years (age ≥ 18 years) were invited to participate in an anonymous online survey. After informed consent was obtained, nonidentifiable data were collected and analyzed.
Of all participants (n = 612), 42% (n = 257) reported using cannabis for relief of symptoms, which included pain (78%), insomnia (70%), anxiety (57%), stress (51%), and nausea/vomiting (46%). Furthermore, 49% of cannabis users believed that medical cannabis could be used to treat cancer itself. Of those taking cannabis, 79% had used it during treatment, which included systemic therapies, radiation, and surgery. At the same time, few (39%) had discussed it with any of their physicians.
A significant percentage of survey participants (42%) used cannabis to address symptoms; approximately half of these participants believed that cannabis could treat cancer itself. Most participants used cannabis during active cancer treatment despite the potential for an adverse event during this vulnerable time. Furthermore, most participants believed that cannabis was safe and were unaware that product quality varied widely and depended on the source. This study reviews the research on medicinal cannabis in the setting of these findings to help physicians to recognize its risks and benefits for patients with cancer.
Almost half of patients with breast cancer use cannabis, most commonly during active treatment to manage common symptoms and side effects: pain, anxiety, insomnia, and nausea. However, most patients do not discuss cannabis use with their physicians. Instead, the internet and family/friends are the most common sources of cannabis information. Furthermore, most participants believe that cannabis products are safe and are unaware that the safety of many products is untested.
本研究旨在描述乳腺癌患者的大麻使用情况,包括他们使用大麻的原因和时间、获取大麻信息和产品的来源、对所获取信息的满意度、对大麻安全性的看法,以及他们与医生就大麻进行的对话。
本研究邀请了在美国的 Breastcancer.org 和 Healthline.com 社区成员参与一项匿名在线调查,这些成员自我报告在 5 年内被诊断出患有乳腺癌(年龄≥18 岁)。在获得知情同意后,收集并分析了不可识别的数据。
在所有参与者中(n=612),42%(n=257)报告使用大麻缓解症状,包括疼痛(78%)、失眠(70%)、焦虑(57%)、压力(51%)和恶心/呕吐(46%)。此外,49%的大麻使用者认为医用大麻可用于治疗癌症本身。在使用大麻的人群中,79%的人在治疗期间使用过,包括系统治疗、放疗和手术。与此同时,很少(39%)人与任何医生讨论过此事。
相当一部分调查参与者(42%)使用大麻来缓解症状;其中约一半参与者认为大麻可以治疗癌症本身。大多数参与者在癌症活跃期使用大麻,尽管在这个脆弱时期使用大麻有潜在的不良反应风险。此外,大多数参与者认为大麻是安全的,并且不知道产品质量差异很大,取决于来源。本研究回顾了医用大麻在这些发现背景下的研究,以帮助医生认识到其对癌症患者的风险和益处。
近一半的乳腺癌患者使用大麻,最常见的是在积极治疗期间,用于缓解常见的症状和副作用:疼痛、焦虑、失眠和恶心。然而,大多数患者不会与医生讨论大麻的使用情况。相反,互联网和家人/朋友是获取大麻信息的最常见来源。此外,大多数参与者认为大麻产品是安全的,并且不知道许多产品的安全性未经测试。